Trokendi XR Helps Partial Onset and Seizures Associated with Lennox-Gastaut Syndrome The Food & Drug Administration has issued final approval for Trokendi XR, an extended-release oral formulation of topiramate for treatment of epilepsy...
DEA Delays Threaten to Hurt People Living with Seizures The Epilepsy Foundation calls on the Drug Enforcement Administration (DEA) to revise its process for reviewing new treatments. The current method dampens innovation and lacks transparency...
A newly-released report from Pharmaceutical Research and Manufacturers of America (PhRMA) has revealed that nearly 450 new medicines are in development to treat neurological disorders, including 28 for epilepsy and seizures. "The Epilepsy...
Epilepsy Foundation's Asian American Outreach Campaign Garnering Widespread Support Campaign is raising awareness about epilepsy by sharing key facts, starting conversations and asking individuals to share their story LANDOVER, Md.--On July 10...
AurimMed Pharma, Inc. and Hövding Named First Recipients of Award and $25,000 Prizes Landover, MD, July 11, 2013 – The Epilepsy Foundation, a national organization dedicated to serving all people with seizures, today launched the Epilepsy...

Pages